Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
D L CohnM C Raviglione

Abstract

The emergence of strains of Mycobacterium tuberculosis that are resistant to antimycobacterial agents is a worldwide problem whose global magnitude is not well described. We reviewed and tabulated 63 surveys of resistance to antituberculous drugs that were performed between 1985 and 1994. Rates of primary resistance to isoniazid, administered as a single agent, ranged from 0 to 16.9% (median rate, 4.1%); to streptomycin, 0.1%-23.5% (median, 3.5%); to rifampin, 0-3.0% (median, 0.2%); and to ethambutol, 0-4.2% (median, 0.1%). The rates of acquired resistance to these agents, which were higher than those of primary resistance, were as follows: isoniazid, 4.0%-53.7% (median rate, 10.6%); streptomycin, 0-19.4% (median, 4.9%); rifampin 0-14.5% (median, 2.4%); and ethambutol, 0-13.7% (median, 1.8%). The highest rates of multidrug-resistant tuberculosis have been reported in Nepal (48.0%), Gujarat, India (33.8%), New York City, (30.1%), Bolivia (15.3%), and Korea (14.5%). The WHO (World Health Organization) and the IUATLD (International Union Against Tuberculosis and Lung Disease) have established a global project of drug resistance surveillance that is based on standard epidemiological methods and quality control through an extensive ...Continue Reading

Citations

Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R S RemisL Vernich
Sep 19, 2000·Infection and Immunity·O OlakanmiL S Schlesinger
Jul 18, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Adnan T AbalEiman Mokaddas
Aug 31, 2002·Phytotherapy Research : PTR·A H JanuárioS C França
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Srinivas V RamaswamyEdward A Graviss
Sep 25, 2004·Medicinal Research Reviews·Rama P TripathiVinod K Tiwari
Dec 13, 2006·Annals of Saudi Medicine·Khaled K Abu-Amero
May 9, 2007·Cadernos de saúde pública·Luciana Martins RozmanMauro Abrahão Rozman
Sep 16, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·A E AniS L Pitmang
Mar 24, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matteo ZignolMario Raviglione
Apr 20, 1999·Radiology·A N Leung
Jan 5, 2002·The Korean Journal of Internal Medicine·J H Lee, J H Chang
Jun 28, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Annika KrüünerMarika Mikelsaar
Jul 15, 2003·Clinical Microbiology Reviews·Sergei B Vakulenko, Shahriar Mobashery
Jul 30, 2004·The Journal of Antimicrobial Chemotherapy·Giovanni Di Perri, Stefano Bonora
Aug 18, 2009·Angewandte Chemie·K C NicolaouWeiqiang Zhan
Mar 17, 2012·Bulletin of the World Health Organization·Matteo ZignolMario Raviglione
Jun 27, 2014·Asian Spine Journal·Sanganagouda Shivanagouda PatilAbhay Madhusudan Nene
Aug 2, 2015·Analytical and Bioanalytical Chemistry·Shinnosuke InoueJae-Hyun Chung
Jan 30, 1999·American Journal of Respiratory and Critical Care Medicine·M E WewersJ Turner
May 18, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·P Shears
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S LockmanJ Tappero
Jan 25, 2002·Annals of the New York Academy of Sciences·Z F Udwadia
Oct 4, 2005·Alimentary Pharmacology & Therapeutics·F M Sanai, K I Bzeizi
Sep 15, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sukhesh Rao
Jan 29, 2008·BMC Infectious Diseases·Ellen M Zager, Ruth McNerney
Jun 16, 2012·Journal of Biomedicine & Biotechnology·J R Goldsmith, Christian Jobin
May 15, 2012·Nature Reviews. Microbiology·Christian LienhardtMario Raviglione

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Journal of Infection in Developing Countries
Jorge Zazueta-BeltranAdrián Canizalez-Roman
MMWR. Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention (CDC)
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Zofia Zwolska, Ewa Augustynowicz-Kopeć
Respirology : Official Journal of the Asian Pacific Society of Respirology
Guobin WangGengrong Zhang
© 2022 Meta ULC. All rights reserved